Amy Slenker

581 total citations · 1 hit paper
7 papers, 335 citations indexed

About

Amy Slenker is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Amy Slenker has authored 7 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 2 papers in Epidemiology and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Amy Slenker's work include Antifungal resistance and susceptibility (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Fungal Infections and Studies (2 papers). Amy Slenker is often cited by papers focused on Antifungal resistance and susceptibility (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Fungal Infections and Studies (2 papers). Amy Slenker collaborates with scholars based in United States and India. Amy Slenker's co-authors include Abdul Aleem, Abdul Samad, Scott W. Keith, David L. Horn, Joseph DeSimone, Michael Moussouttas, Donald Jungkind, John A. DeSimone, David Horn and Stacey D. Smith and has published in prestigious journals such as CHEST Journal, Journal of Clinical Microbiology and Medical Mycology.

In The Last Decade

Amy Slenker

7 papers receiving 328 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19)

2021 226 citations Abdul Aleem, Abdul Samad et al. Europe PMC (PubMed Central) profile →

Peers

Amy Slenker

ID

EPIDE

MB

NEURO

SURGE

Hitoshi Kawasuji Japan

Derek L.L. Hung Hong Kong

Min-Kyung Kim South Korea

Alexander Rombauts Spain

Yuki Miyajima Japan

Muna Al Maslamani Qatar

Adnan Mushtaq United States

Meital Elbaz Israel

María Gori Italy

Ali Toloue Ostadgavahi Canada

Hitoshi Kawasuji Japan

Amy Slenker

304 ×1.2

ID

62 ×0.7

EPIDE

37 ×0.8

MB

52 ×1.2

NEURO

16 ×0.6

SURGE

Citations per year, relative to Amy Slenker Amy Slenker (= 1×) peers Hitoshi Kawasuji

Countries citing papers authored by Amy Slenker

Since Specialization

Citations

This map shows the geographic impact of Amy Slenker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Slenker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Slenker more than expected).

Fields of papers citing papers by Amy Slenker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Slenker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Slenker. The network helps show where Amy Slenker may publish in the future.

Co-authorship network of co-authors of Amy Slenker

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Slenker. A scholar is included among the top collaborators of Amy Slenker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Slenker. Amy Slenker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Aleem, Abdul, Abdul Samad, & Amy Slenker. (2021). Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19). Europe PMC (PubMed Central). 1. 1–1. 226 indexed citations breakdown →

2.

Aleem, Abdul & Amy Slenker. (2021). Monoclonal Antibody Therapy For High-Risk Coronavirus (COVID 19) Patients With Mild To Moderate Disease Presentations. Europe PMC (PubMed Central). 1. 1. 8 indexed citations

3.

Slenker, Amy, et al.. (2020). A FATAL CASE OF CARDIOMYOPATHY SECONDARY TO HUMAN GRANULOCYTIC ANAPLASMOSIS IN AN IMMUNOCOMPROMISED PATIENT. CHEST Journal. 158(4). A235–A235. 2 indexed citations

4.

Slenker, Amy, et al.. (2013). Candidacerebral abscesses: a case report and review of the literature. Medical Mycology. 51(7). 779–784. 27 indexed citations

5.

Slenker, Amy, Scott W. Keith, & David L. Horn. (2012). Two hundred and eleven cases of Candida osteomyelitis: 17 case reports and a review of the literature. Diagnostic Microbiology and Infectious Disease. 73(1). 89–93. 58 indexed citations

6.

Slenker, Amy, et al.. (2012). Fatal Case of Weeksella virosa Sepsis. Journal of Clinical Microbiology. 50(12). 4166–4167. 13 indexed citations

7.

Neofytos, Dionysios, Amy Slenker, & David Horn. (2007). Association of Candidemia Incidence, Candida spp. Epidemiology and Antifungal Use in a Tertiary Care Center.. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact